Military psychiatry

Dr. Jay's Naturals Selects The Birdwell Foundation For PTSD As Primary Charity Recipient

Retrieved on: 
Tuesday, July 20, 2021

HOUSTON, July 20, 2021 /PRNewswire/ -- Mr. Gene Birdwell, majority stockholder of Dr. Jay's Naturals, announces adoption of the Birdwell Foundation for PTSD as the charitable recipient of 20% of profits from Dr. Jay's proprietary products.

Key Points: 
  • HOUSTON, July 20, 2021 /PRNewswire/ -- Mr. Gene Birdwell, majority stockholder of Dr. Jay's Naturals, announces adoption of the Birdwell Foundation for PTSD as the charitable recipient of 20% of profits from Dr. Jay's proprietary products.
  • Dr. Jay's Naturals would like to inspire other businesses and individuals to support the Birdwell Foundation for PTSD 's work on behalf of those suffering PTSD and related illnesses.
  • Helping Birdwell reach, serve and help restore more veterans and first responders is consistent with the mission of Dr. Jay's Naturals ( https://drjaysnaturals.com ).
  • Even more PTSD suffers can be reached if more companies and product lines follow suit and support the Foundation.

Birdwell Foundation Is Opening Camp Valor In Texas For Veterans And First Responders With PTSD

Retrieved on: 
Thursday, July 15, 2021

HOUSTON, July 15, 2021 /PRNewswire/ -- The Birdwell Foundation for PTSD announces the opening this summer of Camp Valor in Conroe, Texas for Veterans and First Responders recovering from PTSD and addictions.

Key Points: 
  • HOUSTON, July 15, 2021 /PRNewswire/ -- The Birdwell Foundation for PTSD announces the opening this summer of Camp Valor in Conroe, Texas for Veterans and First Responders recovering from PTSD and addictions.
  • The Camp currently provides a two-story brick home with beds for 16 people, large country kitchen and two fireplaces, a saltwater pool, and two barns.
  • Stay informed and see the current Wish List of items to complete Camp set-up on the "Friends of Camp Valor" Facebook page, https://www.facebook.com/BirdwellFoundationCampValor .
  • The Birdwell Foundation for PTSD ( www.BirdwellFoundation.org ) is a Houston, Texas-based non-profit organization serving Veterans and First Responders suffering from PTSD and related illnesses.

American Hop Supplier Partners with K9s For Warriors for their 4th Annual Veterans Blend in Support of Military Heroes

Retrieved on: 
Thursday, July 8, 2021

Currently in its 4th year, this hop blend supports and celebrates US military Veterans while collaborating with brewers to create something bigger than beer.

Key Points: 
  • Currently in its 4th year, this hop blend supports and celebrates US military Veterans while collaborating with brewers to create something bigger than beer.
  • A new blend of hops for the Veterans Blend is selected each year by military Veteran brewers across the states.
  • This year, YCH is proud to partner with K9s For Warriors , the largest provider of Service Dogs trained to aid military Veterans in everyday life.
  • www.yakimachief.com
    Determined to end Veteran suicide, K9s For Warriors provides highly-trained Service Dogs to military Veterans suffering from PTSD, traumatic brain injury and/or military sexual trauma.

New Report Highlights PTSD Risk Factors in Women Veterans

Retrieved on: 
Friday, June 25, 2021

The research is presented in a WWP white paper, Women Warriors: Understanding PTSD Risk in a Rapidly Growing Population .

Key Points: 
  • The research is presented in a WWP white paper, Women Warriors: Understanding PTSD Risk in a Rapidly Growing Population .
  • With PTSD Awareness Month in June, WWP is analyzing the risk factors that contribute to PTSD symptoms in women veterans registered with WWP.
  • The analysis also examines how readily women warriors can access mental health care and concludes that nearly half of women warriors with PTSD experience challenges.
  • The nonprofit also developed the Women Warriors Initiative to better understand, empower, and advocate for women warriors.

Virpax to Use Envelta™ IND Enabling Study Results for Two Additional Indications

Retrieved on: 
Monday, June 21, 2021

NCATS has commenced the IND enabling studies of Envelta to support Virpaxs future application for clearance from the Food and Drug Administration (FDA) to initiate Virpaxs first-in-human clinical trials.

Key Points: 
  • NCATS has commenced the IND enabling studies of Envelta to support Virpaxs future application for clearance from the Food and Drug Administration (FDA) to initiate Virpaxs first-in-human clinical trials.
  • Sheila Mathias, PhD, JD, Chief Scientific Officer of Virpax stated, Once the Envelta IND enabling studies are submitted to the FDA for acute/chronic pain, the parent IND is expected to be used to cross reference for the PTSD IND.
  • We believe the same Phase I Single Ascending Dose (SAD)/Multiple Ascending Dose (MAD) study could be used to advance all three indications.
  • Once the Envelta IND enabling studies are submitted to the FDA, the data may be cross-referenced to our cancer pain and PTSD INDs.

Post-Traumatic Stress Disorder Therapeutics Market Report 2021-2029: Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 15, 2021

The "Post-Traumatic Stress Disorder Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Post-Traumatic Stress Disorder Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering.
  • Post-Traumatic Stress Disorder Therapeutics Market: Overview
    The market has been categorized and sub-categorized on the basis of Stage, Age-Specific, Products, End Users and geography.
  • Post-Traumatic Stress Disorder Therapeutics Market: Drivers and Challenges
    The rising prevalence of post-traumatic stress disorder is the primary driver of the global market for post-traumatic stress disorder medications.
  • Post-Traumatic Stress Disorder Therapeutics Market: Markets and Key Player
    The global Post- Traumatic Stress Disorder Therapeutics market was dominated by the United States.

ProfNet Expert Alerts for June 07, 2021

Retrieved on: 
Tuesday, June 8, 2021

energy is truly the core of everything; when you shift the energetics, everything else shifts automatically."

Key Points: 
  • energy is truly the core of everything; when you shift the energetics, everything else shifts automatically."
  • The Secret to Unlocking Buried Emotions Buried emotions are drawn to certain organs in our bodies.
  • "Dogs working in the police force and military can be changed forever by their service, ending up in shelters and suffering serious psychological repercussions, including PTSD."
  • What I learned at medical school was about cure, but what I didn't really learn about is about healing.

Elara Caring Launches New Veteran PTSD Clinical Recovery Program

Retrieved on: 
Friday, May 28, 2021

Elara Caring has developed an in-home treatment program to identify and support veterans' understanding of PTSD and its impact on physical reactions, emotions, and perceptions.

Key Points: 
  • Elara Caring has developed an in-home treatment program to identify and support veterans' understanding of PTSD and its impact on physical reactions, emotions, and perceptions.
  • As a leader in home-based care, we are uniquely positioned to support Veterans with accommodating treatment," said Joseph Cramer, President of Behavioral Services at Elara Caring.
  • "We are eager to launch the BRAVE Clinical Program and expand our partnerships with veteran organizations to ensure we are helping as many individuals as possible with their journey to adjust to civilian life.
  • Elara Caring ( www.elara.com ) is one of the nation's largest providers of home-based care, with a footprint in the Northeast, Midwest and South.

Post-Traumatic Stress Disorder Treatment Market - Global Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 26, 2021

The "Post-traumatic Stress Disorder Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Post-traumatic Stress Disorder Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • Lack of awareness about the post-traumatic stress disorder can resist the growth of global post-traumatic stress disorder treatment market.
  • High cost of treatment is also a major restrain for the growth of post-traumatic stress disorder treatment market.
  • Thus, these factors are expected to restrain the growth of global post-traumatic stress disorder treatment market.

Wall Street Unicorns in Process of Changing the Healthcare Landscape

Retrieved on: 
Tuesday, May 18, 2021

Over decades, people have been conditioned to the stigma of these illicit substances, instigated and promoted by the Controlled Substances Act.

Key Points: 
  • Over decades, people have been conditioned to the stigma of these illicit substances, instigated and promoted by the Controlled Substances Act.
  • However, Tryp is not immediately focused on treating depression or PTSD like many other companies operating in the space.
  • The 505(b)(2) pathway is a streamlined process that allows drug developers to utilize work done by others to demonstrate the safety of a particular active ingredient.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.